Revvity, Inc.
RVTY · Laboratory Analytical Instruments · $16.0B
Powering up
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read
Revvity, Inc. is not on any of the screens right now. Its relative strength rating is 91, and it sits in Laboratory Analytical Instruments.
Peers
Catalyst roadmap
Nothing dated in the next three months that we can ingest automatically.
Flagged by the market sweep
New 52-week highTape · 2026-09-17
2.1x vol
New 52-week highTape · 2026-09-16
2.3x vol
GappedTape · 2026-09-16
+9.1%
Unusual volumeTape · 2026-09-16
3.6 sigma
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?Zacks Investment Research · 4 days agoEpigenetics Market Intelligence Report 2026: Strong Demand from Oncology, Precision Medicine, Pharmaceutical Research, and Liquid-Biopsy DevelopmentGlobeNewswire Inc. · 11 days agoGlobal Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareGlobeNewswire Inc. · 2026-09-04
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray